An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.
Eosinophilic Esophagitis
About this trial
This is an interventional treatment trial for Eosinophilic Esophagitis focused on measuring eosinophilic esophagitis, maintenance treatment, compliance, intervention
Eligibility Criteria
Inclusion Criteria: Written informed consent Male or female patient Age >18 years Previous diagnosis of EoE, confirmed by histopathology, with the presence of >15 eosinophilic granulocytes per high power field (hpf) in esophageal biopsies Current maintenance treatment for EoE with a PPI or swallowed topical corticosteroids or about to start with these maintenance medications as decided during regular clinical practice Exclusion Criteria: Severe and clinically unstable concomitant disease that may interfere with the subject's ability to participate in the study Receive investigational treatment during the study Dilation of esophagus required Insufficient Dutch or English language skills to understand patient information leaflets
Sites / Locations
- Amsterdam UMC, location AMCRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention
Control